Highbridge Capital Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-7,164
Closed -$214K 1742
2015
Q4
$214K Sell
7,164
-6,256
-47% -$211K ﹤0.01% 1315
2015
Q3
$423K Sell
13,420
-3,329
-20% -$162K 0.01% 1097
2015
Q2
$810K Buy
16,749
+7,437
+80% +$313K 0.01% 790
2015
Q1
$404K Buy
+9,312
New +$335K 0.01% 1026
2014
Q4
Sell
-30,553
Closed -$542K 1374
2014
Q3
$542K Buy
+30,553
New +$624K 0.01% 832

Other funds holding PGEN

Highbridge Capital Management's PGEN Position: Q2 2016 in Review

Highbridge Capital Management sold out of Precigen (PGEN) in Q2 2016, closing a stake of 8,254 shares — an estimated $277K sold.

Highbridge Capital Management first reported a position in PGEN in Q3 2014 and held it in 3 quarters. The position peaked at $324K in Q3 2015. 169 funds tracked by Wall St. Rank hold PGEN as of Q2 2016.

  • Highbridge Capital Management reported no remaining Precigen position as of Q2 2016 after selling out during the quarter.
  • Highbridge Capital Management sold 8,254 Precigen shares in Q2 2016, an estimated $277K.
  • Highbridge Capital Management first reported a position in Precigen in Q3 2014 and held it in 3 quarters.
  • Highbridge Capital Management's Precigen position peaked at $324K in Q3 2015.
  • 169 funds tracked by Wall St. Rank held Precigen as of Q2 2016.

Based on Highbridge Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.